IDEAS home Printed from https://ideas.repec.org/h/pal/palchp/978-1-4039-2024-9_7.html
   My bibliography  Save this book chapter

Getting to the Future First and the e-Business Leadership Challenge: Business Driven Action Learning at Lilly

In: Action Learning Worldwide

Author

Listed:
  • Scott Byrd
  • Laura Dorsey

Abstract

Eli Lilly and Company is a global research-based pharmaceutical corporation dedicated to creating and delivering innovative pharmaceutical-based healthcare solutions. Our products address previously unmet medical needs and often reduce the cost of disease, thereby providing significant health and economic benefits for patients, providers and payers. Lilly employs more than 30 000 people worldwide and markets its medicines in 179 countries. The company has major research and development facilities in nine countries and conducts clinical trials in more than 30. Since it was founded more than a century ago, Lilly has been at the forefront of many of the most significant breakthroughs in modern medicine. Lilly was among the first companies to develop a method to massproduce penicillin, the world’s first antibiotic, and in 1982 introduce Humulin® — the first human insulin. Then in 1988, Lilly launched Prozac®, the first in a new class of drugs for treatment of clinical depression. Prozac remains the world’s most widely prescribed antidepressant.

Suggested Citation

  • Scott Byrd & Laura Dorsey, 2002. "Getting to the Future First and the e-Business Leadership Challenge: Business Driven Action Learning at Lilly," Palgrave Macmillan Books, in: Yury Boshyk (ed.), Action Learning Worldwide, chapter 7, pages 110-122, Palgrave Macmillan.
    • Handle: RePEc:pal:palchp:978-1-4039-2024-9_7
    DOI: 10.1057/9781403920249_7
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:palchp:978-1-4039-2024-9_7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.